About Biogeny Diagnostics
Biogeny Diagnostics is a company based in Navsari (India) founded in 2009 by Bruno Attilio Pizzochero, Jignesh Bhulabhai Patel, and Bipinchandra Ishwarlal Parekh. It operates as a B2B. The company has 76 employees as of March 31, 2022.
- Headquarter Navsari, India
- Employees 76 as on 31 Mar, 2022
- Founders Bruno Attilio Pizzochero, Jignesh Bhulabhai Patel, Bipinchandra Ishwarlal Parekh
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biogeny Diagnostics Private Limited
- Date of Incorporation 13 Jul, 2009
- Jurisdiction Navsari, Gujarat, India
-
Annual Revenue
$3.32 M (USD)90.07as on Mar 31, 2022
-
Net Profit
$446.49 K (USD)522.34as on Mar 31, 2022
-
EBITDA
$618.63 K (USD)393.14as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
76
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biogeny Diagnostics
Detailed funding history for Biogeny Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biogeny Diagnostics
Investment portfolio details for Biogeny Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biogeny Diagnostics
Detailed financials for Biogeny Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biogeny Diagnostics Comparisons
Peer comparison for Biogeny Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biogeny Diagnostics
Detailed competitors of Biogeny Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biogeny Diagnostics
Complete news archive for Biogeny Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biogeny Diagnostics
Biogeny Diagnostics was founded in 2009.
Biogeny Diagnostics is headquartered in Navsari, India. It is registered at Navsari, Gujarat, India.
As of Mar 31, 2022, the latest employee count at Biogeny Diagnostics is 76.
Annual revenue of Biogeny Diagnostics is $3.32M as on Mar 31, 2022.
Biogeny Diagnostics, founded in 2009 in Navsari, India, focuses on providing healthcare solutions, developing medical devices, diagnostic tools, and clinical chemistry. Supplies reagents and instruments for clinical diagnostic chemistry applications. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.